Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Eplerenone in Patients with Systolic Heart Failure and Mi... | ResearchHub

Paper

Paper

Supporters

Support the authors with ResearchCoin

Journal

New England Journal of Medicine

Topics

Internal Medicine

Endocrinology, Diabetes And Metabolism

Pulmonary And Respiratory Medicine

DOI

10.1056/nejmoa1009492

Changelog Terms Privacy Issues Docs Support Foundation About

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

0

Authors

Faı̈ez Zannad

Faı̈ez Zannad•Henry Krum•Bertram Pitt

Published

November 14, 2010

Abstract

Mineralocorticoid antagonists improve survival among patients with chronic, severe systolic heart failure and heart failure after myocardial infarction. We evaluated the effects of eplerenone in patients with chronic systolic heart failure and mild symptoms.

Supporters

Support the authors with ResearchCoin

Journal

New England Journal of Medicine

Topics

Internal Medicine

Endocrinology, Diabetes And Metabolism

Pulmonary And Respiratory Medicine

DOI

10.1056/nejmoa1009492